Method for diagnosing heart failure
AssigneeChang Gung University
InventorsChao-Hung Wang, Ming-Shi Shiao, Mei-Ling Cheng
Life of this patent
Estimating the term…
Abstract
A method for diagnosing heart failure in a subject is provided. The method includes steps of measuring a biological sample of the subject to obtain an amount of at least one biomarker selected from the group consisting of xanthine, spermidine, propionylcarnitine, butyrylcarnitine and P-cresyl sulfate; and comparing the amount of the at least one biomarker to a reference. Moreover, the present invention relates to a method for staging heart failure or evaluating a prognosis of heart failure in a subject.
Claims21
A method for diagnosing heart failure in a subject, comprising steps of:
- measuring a biological sample of the subject to obtain an amount of at least one biomarker selected from the group consisting of xanthine, spermidine, propionylcarnitine, butyrylcarnitine and P-cresyl sulfate;
- and
- comparing the amount of the at least one biomarker to a reference,
A method for staging heart failure in a subject, comprising steps of:
- measuring a biological sample of the subject to obtain an amount of at least one biomarker selected from the group consisting of xanthine, spermidine and propionylcarnitine;
- and
- comparing the amount of the at least one biomarker to a reference.
A method for evaluating a prognosis of heart failure in a subject, comprising steps of:
- measuring a biological sample of the subject to obtain an amount of at least one biomarker selected from the group consisting of xanthine, spermidine, butyrylcarnitine and P-cresyl sulfate;
- and
- comparing the amount of the at least one biomarker to a reference.
A diagnostic device for diagnosing heart failure comprising:
- a detector for detecting a biomarker selected from the group consisting of xanthine, spermidine, propionylcarnitine, butyrylcarnitine, P-cresyl sulfate and a combination thereof.
Dependencies are inferred from the claim text.